Morphology, Crystal Size and Crystallinity Degree of Silica-Calcium Phosphate Composite (S) and Apatite Cement Formulation - In Vitro Bioactivity Test

Abstract:

Silica-calcium phosphate nanocomposite (SCPC) is a porous bioactive resorbable bioactive ceramics. Incorporating apatite bone cement (AC) formulation of tetracalcium phosphate-dicalcium phosphate dihydrate and SCPC has contributed to the higher mechanical strength of a new prototype apatite cement formulation. This in-vitro experiment aims to investigate the bioactivity of AC formulation using simulated body fluid (SBF). The samples consist of two groups of AC formulations (n=4). The first group, AC with 10% SCPC and the second group AC without SCPC, was immersed in the SBF for 14 days. The samples before and after immersion were analyzed by X-Ray Diffraction (XRD), Energy Dispersive X-ray Spectroscopy (EDS), and Scanning Electron Microscope (SEM). The samples' size and degree of crystallinity were analyzed statistically using Shapiro-Wilk, Levene, and Mann-Whitney test. As a result, there was no significant difference in the crystal size and the degree of the crystallinity of both samples. The surface morphology of all samples were coated with hydroxyapatite after immersing in the SBF solution. Both AC formulations with and without SCPC have bioactivity as the bone substitute materials. Combining AC with SCPC50 is a promising method to improve the bioactivity and mechanical strength of calcium phosphate bone cement.

• Periodical: Materials Science Forum (Volume 1069)
• Pages: 121-128
• DOI: https://doi.org/10.4028/p-53nqp6
• Online since: August 2022
• Authors: Ira Artilia*, Atia Nurul Sidiqa, Zalfa Puspa Fakhira, Myrna Nurlatifah Zakaria, Ahmed El-Ghannam, Arief Cahyanto
• Keywords: Apatite Cement, Bioactivity, Crystallinity, Silica

References

[1] Chow LC. Development of self-setting calcium phosphate cements. Nippon Seramikkusu Kyokai Gakujutsu Ronbunshi/Journal Ceram Soc Japan. 1991;99(1154):954–64.

DOI: 10.2109/jcersj.99.954

[2] Brown WE, Chow LC. Paste mineralizers and cements. 1986. p. US Patent No.4612053.

[3] Ishikawa K. Calcium phosphate cement. In: Kokubo T, editor. Bioceramics and their clinical applications. Woodhead Publishing anf Maney Publishing; 2008. p.438–62.

[4] Ambard AJ, Mueninghoff L. Calcium phosphate cement: Review of mechanical and biological properties. J Prosthodont. 2006;15(5):321–8.

DOI: 10.1111/j.1532-849x.2006.00129.x

[5] Dorozhkin S V. Calcium orthophosphate cements for biomedical application. J Mater Sci. 2008;43(9):3028–57.

DOI: 10.1007/s10853-008-2527-z

[6] Ishikawa K, Asaoka K. Estimation of ideal mechanical strength and critical porosity of calcium phosphate cement. J Biomed Mater Res. 1995;29(12):1537–43.

DOI: 10.1002/jbm.820291210

[7] Watanabe M, Tanaka M, Sakurai M, Maeda M. Development of calcium phosphate cement. J Eur Ceram Soc. 2006;26(4–5):549–52.

[8] Dos Santos LA, De Oliveira LC, Da Silva Rigo EC, Garcia Carrodéguas; R, Boschi AO, De Arruda ACF. Fiber reinforced calcium phosphate cement. Artif Organs. 2000;24(3):212–6.

DOI: 10.1046/j.1525-1594.2000.06541.x

[9] Hesaraki S, Alizadeh M, Borhan S, Pourbaghi-Masouleh M. Polymerizable nanoparticulate silica-reinforced calcium phosphate bone cement. J Biomed Mater Res - Part B Appl Biomater. 2012;100 B(6):1627–35.

DOI: 10.1002/jbm.b.32731

[10] El-Ghannam AR. Advanced bioceramic composite for bone tissue engineering: Design principles and structure-bioactivity relationship. J Biomed Mater Res - Part A. 2004;69(3):490–501.

DOI: 10.1002/jbm.a.30022

[11] Cahyanto A, Rezano A, Zakaria MN, El-Ghannam A. Synthesis and Characterization of a Novel SCPC-CO3Ap Cement for Pulp Capping Application in Dentistry. Key Eng Mater. 2017;758:29–33.

DOI: 10.4028/www.scientific.net/kem.758.29

[12] Zakaria MN, Cahyanto A, El-Ghannam A. Basic properties of novel bioactive cement based on silica-calcium phosphate composite and carbonate apatite. Key Eng Mater. 2017;720:147–52.

DOI: 10.4028/www.scientific.net/kem.720.147

[13] Kokubo T, Takadama H. Simulated Body Fluid (SBF) as a Standard Tool to Test the Bioactivity of Implants. In: Handbook of Biomineralization: Biological Aspects and Structure Formation. 2008. p.97–109.

DOI: 10.1002/9783527619443.ch51

[14] Bohner M, Lemaitre J. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009;30(12):2175–9.

DOI: 10.1016/j.biomaterials.2009.01.008

[15] Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27(15):2907–15.

DOI: 10.1016/j.biomaterials.2006.01.017

[16] Artilia I, Zakaria MN, Cahyanto A. Setting time, handling property and mechanical strength evaluation of SCPC50 and apatite cement mixture in various combinations. Key Eng Mater. 2019;829:40–5.

DOI: 10.4028/www.scientific.net/kem.829.40

[17] Yücel S, Aydin I, Özçimen D, Tekerek BS, Yildirim Ö, Kabakci A. Effect of simulated body fluid on the behaviour of artificial bone composite material extended by hydroxyapatite and silicate powders. Key Eng Mater. 2012;493–494:159–65.

DOI: 10.4028/www.scientific.net/kem.493-494.159

[18] Kim HM, Himeno T, Kawashita M, Kokubo T, Nakamura T. The mechanism of biomineralization of bone-like apatite on synthetic hydroxyapatite: An in vitro assessment. J R Soc Interface. 2004;1(1):17–22.

DOI: 10.1098/rsif.2004.0003

[19] Bonar LC, Roufosse AH, Sabine WK, Grynpas MD, Glimcher MJ. X-ray diffraction studies of the crystallinity of bone mineral in newly synthesized and density fractionated bone. Calcif Tissue Int. 1983;35(1):202–9.

DOI: 10.1007/bf02405032

[20] Ishikawa K. Bone substitute fabrication based on dissolution-precipitation reactions. Materials (Basel). 2010;3(2):1138–55.

DOI: 10.3390/ma3021138

[21] Wang X, Ye J, Wang Y, Wu X, Bai B. Control of crystallinity of hydrated products in a calcium phosphate bone cement. J Biomed Mater Res. 2007;81(A)(4):781-90.

DOI: 10.1002/jbm.a.31059